FDA Inspection 1171429 — Innovative Blood Resources, Division Of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, Division Of New York Blood Center, Inc. on May 11, 2022 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 11, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln, NE (United States)